Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Historically Controlled Phase II/III Study to Evaluate Efficacy and Safety of Kedrion Human Plasminogen Eye Drop Preparation in Patients Diagnosed With Ligneous Conjunctivitis

NCT01554956 is registered in ClinicalTrials.gov with Kedrion S.p.A. as lead sponsor.

NCT NCT01554956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01554956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Historically Controlled Phase II/III Study to Evaluate Efficacy and Safety of Kedrion Human Plasminogen Eye Drop Preparation in Patients Diagnosed With Ligneous Conjunctivitis
Lead sponsor
Kedrion S.p.A.
Phase
Phase 2/3
Overall status
Completed
Start date
May 22, 2013
Completion date
December 4, 2020
Enrollment
12 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ligneous conjunctivitis